Randomized Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer (KHBO1208)
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2018
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer; Cholangiocarcinoma
- Focus Therapeutic Use
- 15 May 2018 Status changed from active, no longer recruiting to completed.
- 31 Aug 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 31 Aug 2016 Status changed from recruiting to active, no longer recruiting.